Point of Care Testing for APTT in Patients on Heparin Infusion – Beneficial or Not?doi:10.1016/j.hlc.2017.03.097Surman, TimothyWorthington, MichaelHeart, Lung and Circulation
The Use of Point-of-Care Testing for Monitoring of Activated Partial Thromboplastin Time in Patients Receiving Heparin Infusion is Not SafeThere is a high risk of thromboembolic events among patients undergoing cardiac surgery, and ... S Timothy,W Michael - 《Heart Lung & Circulation》 被引量:...
The degree of prolongation of the aPTT by heparin is difficult to predict and depends on the amount of heparin infused, the time interval between infusion Full Text Download PDF Full Text Cite This Permissions Access through your institution JAMA+ AI Trending Viewpoint Enter the Physician...
How One Academic Medical Center Has Managed Potency Changes with Unfractionated Heparin A retrospective review was conducted on patients receiving UFH and at least one activated partial thromboplastin time (aPTT) after start of infusion. ... J Lalama,PM Lewis,Joel M. Gore,... - 《J Thromb Thr...
An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A. Background: Intravenous unfractionated heparin remains a cornerstone of anticoagulation therapy for patients with acute coronary syndromes, but regulation......
Heparin-induced thrombocytopenia in a uremic patient requiring hemodialysis: an alternative treatment and reexposure to heparin. Optimal dose adjustment of argatroban through activated partial thromboplastin time (APTT) monitoring led to a bolus of 5 mg and continuous infusion of ... T Matsuo,H Kusan...
This was a single-center, retrospective cohort study of critically ill adult patients who had simultaneous anti-Xa and aPTT levels while receiving continuous UFH infusion. The primary outcome was the incidence of a major bleeding event up to 24h after UFH discontinuation. Secondary outcomes included...
Pearson correlation was used to determine the relationship between infusion rate and measured heparin parameters, and logistic regression was performed to identify risk factors associated with the primary outcome. Results: A total of 53 post-VAD patients were eligible for inclusion; 8 patients were ...
Results: Six studies comprising 1728 patients were included in the final analysis. Unfractionated heparin was used for anticoagulation, with an activated partial thromboplastin time (aPTT) monitoring goal set between 45 and 80 s. The majority of studies aimed to investigate the incidence of adverse ...
Zaki, H.V.; Elbeialy, M.A.K.; Soliman, A.M. The Use of Activated Partial Thromboplastin Time versus Antifactor Xa Assay in Monitoring Continuous Unfractionated Heparin Infusion Therapy in Obstetric Intensive Care Unit.Ain-Shams J. Anesthesiol.2019,11, 3. [Google Scholar] [CrossRef] [Gr...